dc.contributor.author |
Huober, Jens |
de_DE |
dc.date.accessioned |
2013-12-06T10:06:49Z |
|
dc.date.available |
2013-12-06T10:06:49Z |
|
dc.date.issued |
2013 |
de_DE |
dc.identifier.issn |
0167-6806 |
de_DE |
dc.identifier.uri |
http://hdl.handle.net/10900/39059 |
|
dc.language.iso |
en |
en |
dc.publisher |
Springer |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1007/s10549-013-2589-8 |
de_DE |
dc.rights |
info:eu-repo/semantics/closedAccess |
|
dc.subject.ddc |
610 |
de_DE |
dc.title |
Capecitabine plus paclitaxel versus epirubicin plus paclitaxel as first-line treatment for metastatic breast cancer: efficacy and safety results of a randomized, phase III trial by the AGO Breast Cancer Study Group |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20130911224530_00539 |
de_DE |
utue.publikation.seiten |
779-787 |
de_DE |
utue.personen.roh |
Lueck, Hans-Joachim |
de_DE |
utue.personen.roh |
Du Bois, Andreas |
de_DE |
utue.personen.roh |
Loibl, Sibylle |
de_DE |
utue.personen.roh |
Schrader, Iris |
de_DE |
utue.personen.roh |
Huober, Jens |
de_DE |
utue.personen.roh |
Heilmann, Volker |
de_DE |
utue.personen.roh |
Beckmann, Matthias |
de_DE |
utue.personen.roh |
Staehler, Ann |
de_DE |
utue.personen.roh |
Jackisch, Christian |
de_DE |
utue.personen.roh |
Hubalek, Michael |
de_DE |
utue.personen.roh |
Richter, Barbara |
de_DE |
utue.personen.roh |
Stickeler, Elmar |
de_DE |
utue.personen.roh |
Eidtmann, Holger |
de_DE |
utue.personen.roh |
Thomssen, Christoph |
de_DE |
utue.personen.roh |
Untch, Michael |
de_DE |
utue.personen.roh |
Wollschlaeger, Kerstin |
de_DE |
utue.personen.roh |
Schuster, Tibor |
de_DE |
utue.personen.roh |
von Minckwitz, Gunter |
de_DE |
dcterms.isPartOf.ZSTitelID |
Breast Cancer Research and Treatment |
de_DE |
dcterms.isPartOf.ZS-Issue |
3 |
de_DE |
dcterms.isPartOf.ZS-Volume |
139 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
de_DE |